Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
---|---|---|---|---|---|---|
SC 13D/A | 2018-01-16 | QVT Financial LP | Arbutus Biopharma Corp | 16,013,540 | 29.1% | EDGAR |
SC 13D/A | 2018-01-16 | SVF Investments (UK) Ltd | Arbutus Biopharma Corp | 16,013,540 | 29.1% | EDGAR |
SC 13D/A | 2017-10-17 | VIKING GLOBAL INVESTORS LP | Arbutus Biopharma Corp | 16,013,540 | 29.1% | EDGAR |
SC 13D/A | 2017-10-17 | Roivant Sciences Ltd. | Arbutus Biopharma Corp | 16,013,540 | 29.1% | EDGAR |
SC 13D/A | 2017-10-17 | Machado Patrick | Arbutus Biopharma Corp | 16,013,540 | 29.1% | EDGAR |
SC 13D/A | 2017-10-17 | Lo Andrew | Arbutus Biopharma Corp | 16,013,540 | 29.1% | EDGAR |
SC 13D/A | 2017-10-17 | Dexxon Holdings Ltd. | Arbutus Biopharma Corp | 16,013,540 | 29.1% | EDGAR |
SC 13D/A | 2017-10-17 | QVT Financial LP | Arbutus Biopharma Corp | 16,013,540 | 29.1% | EDGAR |
SC 13D/A | 2017-10-17 | SVF Investments (UK) Ltd | Arbutus Biopharma Corp | 16,013,540 | 29.1% | EDGAR |
SC 13D/A | 2017-10-03 | Roivant Sciences Ltd. | Arbutus Biopharma Corp | 16,013,540 | 29.1% | EDGAR |
SC 13D | 2017-09-15 | SVF Investments (UK) Ltd | Arbutus Biopharma Corp | 16,013,540 | 29.1% | EDGAR |
SC 13D/A | 2017-07-06 | VIKING GLOBAL INVESTORS LP | Arbutus Biopharma Corp | 16,013,540 | 29.1% | EDGAR |
SC 13D/A | 2017-06-14 | VIKING GLOBAL INVESTORS LP | Arbutus Biopharma Corp | 16,013,540 | 29.1% | EDGAR |
SC 13G | 2017-05-17 | RTW INVESTMENTS, LP | Arbutus Biopharma Corp | 2,770,284 | 5.0% | EDGAR |
SC 13G/A | 2017-02-09 | PRIMECAP MANAGEMENT CO/CA/ | Arbutus Biopharma Corp | 3,935,000 | 7.2% | EDGAR |
SC 13D/A | 2016-10-19 | Lo Andrew | Arbutus Biopharma Corp | 16,013,540 | 29.2% | EDGAR |
SC 13D | 2016-10-19 | Machado Patrick | Arbutus Biopharma Corp | 16,013,540 | 29.2% | EDGAR |
SC 13D | 2016-07-14 | QVT Financial LP | Arbutus Biopharma Corp | 16,013,540 | 29.3% | EDGAR |
SC 13D | 2016-07-13 | VIKING GLOBAL INVESTORS LP | Arbutus Biopharma Corp | 16,013,540 | 29.3% | EDGAR |
SC 13D | 2016-07-13 | Lo Andrew | Arbutus Biopharma Corp | 16,013,540 | 29.3% | EDGAR |